shop now 
The Future is not Chemical – The Future is Alive
We’ve found that certain gut bacteria interact with PFAS, which could help us understand new ways to reduce their presence in the body.
Kiran Raosaheb Patil
Professor of Molecular Systems Biology, University of Cambridge
What are PFAS?
Per-and polyfluoroalkyl substances (PFAS), often referred to as “forever chemicals,” are a large group of human-made compounds used for their water-resistant, oil-resistant, and nonstick properties. PFAS are extremely persistent in the environment and the human body, meaning they do not break down easily and unfortunately accumulate for decades.
How toxic are PFAS?
PFAS compounds can accumulate in nature, plants, animals, and humans. According to the National Academy of Science, Engineering, and Medicine (NASEM), PFAS levels above 2 ng/ml in human blood serum are considered to have potential adverse health effects. The global societal costs, including remediation and healthcare of PFAS chemicals, amount to ~18 trillion per year.
How are we exposed?
PFAS contamination affects various population segments in different ways. Workers in chemical manufacturing, firefighting, textile production, and industries producing nonstick or water- and stain-repellent materials face the highest risk. For the general population, PFAS exposure primarily occurs through consuming contaminated water and food, as well as using consumer products containing these substances.
PFAS Removal
Cambiotics introduces a precision-formulated probiotic that supports the body’s natural process for removal of forever chemicals. Its specialized probiotic strains are designed to interact with PFAS molecules in the gut and may support their natural movement through the digestive system.
Contain probiotic strains that have been shown in scientific studies to bioaccumulate PFAS from their surroundings.
Sign up for the waiting list
Product available in United States in 2026
How many people are exposed to PFAS?
>99%
of people polluted with PFAS
45%
of US Tapwater contaminated with PFAS
9 PFAS
Proposed as hazardous constituents by EPA
The ‘forever chemicals’ in 99% of US population
Today, the family of compounds, commonly called PFAS or forever chemicals, is found not only in pots and pans but also in the blood of people around the world, including 99% of the US population. PFAS chemicals pollute water, do not break down, and remain in the environment and people for decades.
At least 45% of the nation’s tap water is estimated to have one or more types of PFAS
This Unites States Geological Survey or USGS research marks the first time anyone has tested for and compared PFAS in tap water from both private and government-regulated public water supplies on a broad scale throughout the country. Those data were used to model and estimate PFAS contamination nationwide. This USGS study can help members of the public to understand their risk of exposure and inform policy and management decisions regarding testing and treatment options for drinking water.
Proposal to list nine per- and polyfluoroalkyl compounds as resource conservation and recovery act hazardous constituents
On February 8, 2024, EPA proposed changes to the Resource Conservation and Recovery Act regulations by adding nine particular per- and polyfluoroalkyl compounds, their salts, and their structural isomers, to its list of hazardous constituents in Title 40 of the Code of Federal Regulations Part 261 Appendix VIII. These nine PFAS are: Perfluorooctanoic acid, Perfluorooctanesulfonic acid, Perfluorobutanesulfonic acid, Hexafluoropropylene oxide-dimer acid, Perfluorononanoic acid, Perfluorohexanesulfonic acid, Perfluorodecanoic acid, Perfluorohexanoic acid and Perfluorobutanoic acid.
Research partners
Business partners
Beyond the data: Firefighters and PFAS exposure
Partnerships against PFAS
Cambiotics is committed to supporting first responders, including firefighters and military personnel, in managing PFAS exposure. We aim to develop solutions that assist the body’s natural processes in dealing with these persistent chemicals.
Our Team
Peter Holme Jensen is the Chief Executive Officer and co-founder of Cambiotics. Peter holds a Ph.D. in biochemistry from the University of Copenhagen and is a serial entrepreneur with a passion for biomimicry, seeking answers to innovative solutions in nature. The process of innovation is essential to Peter Holme Jensen. “We cannot be sure how long it takes or even where we end up, but we can decide to be passionate about what we do and enjoy the process.” Peter Holme Jensen is also a board member of Aquaporin A/S and Innovation Fund Denmark. Peter Holme Jensen is also a board member of Aquaporin A/S and Innovation Fund Denmark.
Peter Holme Jensen, Ph.D.
Chef Executive officer & Co-founder
Anna is a co-founder and co-inventor at Cambiotics, driven by a passion for translating science into real-world impact. Holding a Ph.D. in Toxicology from the University of Cambridge, she made the leap from academia to entrepreneurship to close the gap between cutting-edge research and practical health solutions. At Cambiotics, Anna leads efforts to address the growing challenge of PFAS exposure through innovative, microbiome-based strategies. Her work focuses on leveraging probiotic science to support human health and advance the frontiers of environmental toxicology.
Anna E. Lindell, Ph.D.
VP Technology and Co-founder
Hitheshi Rathod, Business Developer at Cambiotics, is driven by a simple but powerful belief: healthcare should be accessible, affordable, and rooted in innovation. With a background in medical biotechnology and business in healthcare innovation, Hitheshi has led efforts in market analysis, strategic partnerships, and digital communication. She thrives on transforming complex science into relatable stories that resonate with real people.
Hitheshi Rathod
Business Developer
Steen is an experienced C-level executive with over 30 years in biotechnology, nutrition, and microbiome industries. He has successfully led businesses in the global dietary supplement and OTC sectors, playing key roles in several successful company exits, including Chr. Hansen, Bifodan, and Deerland. Steen brings valuable expertise to our board as we continue to grow and innovate.
Steen Dannemann Andersen
Chairman of the Board
Kiran is a researcher with a background in Chemical Engineering from the Indian Institute of Technology (Mumbai) and a Ph.D. in Systems Biology from the Technical University of Denmark (DTU). Kiran then joined the European Molecular Biology Laboratory (EMBL-Heidelberg) and later became Director of Research at the MRC Toxicology Unit in 2019, before being appointed Professor of Molecular Systems Biology in 2022. His research centers on understanding the complex metabolic networks in the gut microbiota, exploring how these networks affect drug efficacy, action, and toxicity. Using a combination of computational and experimental approaches, Kiran aims to uncover the role of the microbiome in mediating the effects of drugs and environmental contaminants like pesticides.
Prof. Kiran Patil, Ph.D.
Board member and Co-founder
Peter Holme Jensen is the Chief Executive Officer and co-founder of Cambiotics. Peter holds a Ph.D. in biochemistry from the University of Copenhagen and is a serial entrepreneur with a passion for biomimicry, seeking answers to innovative solutions in nature. The process of innovation is essential to Peter Holme Jensen. “We cannot be sure how long it takes or even where we end up, but we can decide to be passionate about what we do and enjoy the process.” Peter Holme Jensen is also a board member of Aquaporin A/S and Innovation Fund Denmark.
Peter Holme Jensen, Ph.D.
Board member and Co-founder
Thomas Durhuus is the VP of Operations at Cambiotics, with over a decade of experience in optimizing business operations within the biotechnology and commercial sectors. He has a strong track record of streamlining processes, improving efficiency, and ensuring smooth day-to-day operations. Thomas is dedicated to driving operational excellence, managing cross-functional teams, and executing strategic initiatives to support Cambiotics’ growth and success.
Thomas Durhuus
Vice President, Operations
Jessica brings extensive experience in microbiology, a sharp eye for detail, and a love for solving scientific puzzles. She’s both creative and methodical, making her the perfect fit for designing and structuring complex lab experiments as we continue advancing our precision probiotics for PFAS detoxification. When she’s not in the lab, Jessica enjoys gardening and spending time with her two dogs, bringing both curiosity and calm wherever she goes.
Jessica Marissen
Laboratory Technician
Media
Publications – Expert insights from the frontlines of PFAS research
Mewburn Ellis
IP Law Firm
Cambiotics: a novel treatment for PFAS ‘forever chemicals’
An elegant natural solution to this pervasive man made problem
Eliot Ward
Partner and Patent Attorney at Mewburn Ellis
How One Company Secretly Poisoned The Planet
The biggest chemical cover up in history, by Veritasium
Kiran Patil and Peter Holme Jensen – Behind the Shield
A deep dive into breakthrough PFAS elimination technology with Cambiotics founders.
PFAS in Firefighters – A True Story
PFAS contaminating the firefighting community.
PFAS in European Teenagers – Forever Podcast
Exploring the rising concern about PFAS contamination across Scandinavian countries.
Our Technology
Extensive PFAS accumulation by human gut bacteria
Cambiotics now offers a precision-formulated probiotic developed to support the body’s natural processes. Its specialized probiotic strains are designed to interact with PFAS molecules in the gut, potentially aiding in the management of their presence through normal digestive activity.
Using biology to remove chemicals from the body
The technology was developed from pioneering research by Dr. Anna Lindell, Cambiotics’ VP of Technology and co-founder, in collaboration with Professor Kiran Patil at the MRC Toxicology Unit, University of Cambridge.
“Our probiotic formulation is designed to support the body’s natural response to PFAS exposure by engaging with these compounds through physiological pathways.” — Dr. Anna E. Lindell
To learn more about our science, we invite you to explore our publication, which presents evidence that specific probiotic strains can interact with PFAS molecules across a range of concentrations, from nanomolar to high micromolar levels.
Extensive PFAS accumulation by human gut bacteria
Dr. Anna E. Lindell & Prof. Kiran Raosaheb Patil
Extensive PFAS accumulation by human gut bacteria
Contact Us
